HOUSTON, May 8, 2014 OrthoAccel® Technologies, Inc. announces that Kelly Enos has joined the company as chief financial officer (CFO) and vice president of finance and administration. As CFO, Enos will oversee all of OrthoAccel’s accounting, finance, information technology, legal and human resources functions. She brings more than 20 years of financial management and operations experience to her new position including prior experience in CFO roles at high tech, start-up and venture-backed companies.
Most recently, Enos served as the chief financial officer for Kony, Inc., the fastest growing enterprise app mobility company in the market.
Throughout her career, Enos has led countless transactions across a variety of debt and equity structures, including initial public offerings as well as mergers and acquisitions. Enos began her career with Ernst & Young and later worked in investment banking at notable firms such as Oppenheimer. A graduate from Louisiana State University, she went on to pursue an MBA from Rice University and is a licensed Certified Public Accountant in Texas.
“We’re excited to bring Kelly Enos onboard here at OrthoAccel as her background, experience and expertise will be a true asset to the company, fueling our next level of growth as the leader in accelerated orthodontics,” said Mike Lowe, president and CEO of OrthoAccel Technologies, Inc. “Her track record includes one growth success story after another, many in innovation and technology-focused industries.”
OrthoAccel manufactures AcceleDent®, the only FDA-cleared, Class II medical device that has been proven to speed up orthodontic treatment by as much as 50 percent. Used in conjunction with orthodontics such as braces, AcceleDent uses SoftPulse Technology® to accelerate tooth movement. The product is now offered in over 1,500 orthodontic offices in the U.S.
Orthodontists and staff members who are interested in learning more about AcceleDent, or how to offer the technology at their practice, can locate an OrthoAccel sales representative at AcceleDent.com/orthodontists or by calling 866-866-4919.
About OrthoAccel® Technologies, Inc.
Based in Houston, Texas, OrthoAccel® Technologies, Inc. is a privately owned medical device company engaged in the development, manufacturing and marketing of products to enhance dental care and orthodontic treatment. OrthoAccel developed and sells AcceleDent® Aura, the first FDA-cleared clinical approach to safely accelerate orthodontic tooth movement by applying gentle micropulses via SoftPulse Technology® as a complement to existing orthodontic treatment. More information can be found at acceledent.com and acceledent.co.uk or requested via email@example.com.